Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001422454 | SCV001625004 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002259120 | SCV002529944 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-02 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002259120 | SCV002713529 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001422454 | SCV004836900 | likely benign | Multiple endocrine neoplasia, type 2 | 2024-01-11 | criteria provided, single submitter | clinical testing |